| Primary |
| Chronic Obstructive Pulmonary Disease |
32.5% |
| Asthma |
26.8% |
| Product Used For Unknown Indication |
5.4% |
| Hypertension |
5.0% |
| Dyspnoea |
4.3% |
| Bronchospasm |
2.8% |
| Bronchitis |
2.6% |
| Emphysema |
2.5% |
| Respiratory Tract Infection |
2.4% |
| Pneumonia |
2.1% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Rhinorrhoea |
1.8% |
| Diabetes Mellitus |
1.5% |
| Elevated Mood |
1.4% |
| Pyrexia |
1.4% |
| Bronchiectasis |
1.2% |
| Rhinitis |
1.2% |
| Asthmatic Crisis |
1.1% |
| Epilepsy |
1.1% |
| Pain |
1.1% |
|
| Off Label Use |
18.4% |
| Death |
15.0% |
| Asthma |
6.3% |
| Pneumonia |
5.8% |
| Tremor |
5.8% |
| Drug Ineffective |
5.3% |
| Product Quality Issue |
4.9% |
| Tachycardia |
4.4% |
| Dyspnoea |
3.9% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Tachypnoea |
3.4% |
| Vision Blurred |
3.4% |
| Urticaria |
2.9% |
| Visual Impairment |
2.9% |
| Chest Discomfort |
2.4% |
| Lymphoma |
2.4% |
| Rhinorrhoea |
2.4% |
| Vomiting |
2.4% |
| Wheezing |
2.4% |
| Arrhythmia |
1.9% |
|
| Secondary |
| Asthma |
22.4% |
| Product Used For Unknown Indication |
19.5% |
| Chronic Obstructive Pulmonary Disease |
17.1% |
| Drug Use For Unknown Indication |
13.5% |
| Hypertension |
5.2% |
| Bronchitis |
2.5% |
| Emphysema |
2.3% |
| Dyspnoea |
2.3% |
| Ill-defined Disorder |
1.9% |
| Breast Cancer |
1.8% |
| Pain |
1.5% |
| Osteoporosis |
1.4% |
| Pneumonia |
1.4% |
| Asthmatic Crisis |
1.2% |
| Cardiac Failure |
1.2% |
| Atrial Fibrillation |
1.0% |
| Bronchospasm |
1.0% |
| Depression |
1.0% |
| Prophylaxis |
0.9% |
| Pulmonary Fibrosis |
0.8% |
|
| Pneumonia |
10.4% |
| Tachycardia Foetal |
8.1% |
| Wheezing |
7.5% |
| Dyspnoea |
6.9% |
| Weight Decreased |
6.9% |
| Hyponatraemia |
6.4% |
| Chronic Obstructive Pulmonary Disease |
5.8% |
| Tremor |
5.8% |
| Drug Ineffective |
5.2% |
| Rash |
4.6% |
| Vomiting |
4.6% |
| Hypothyroidism |
3.5% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
3.5% |
| Toxic Epidermal Necrolysis |
3.5% |
| Death |
2.9% |
| Dizziness |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Lymphoma |
2.9% |
| Product Quality Issue |
2.9% |
| Respiratory Failure |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.9% |
| Drug Use For Unknown Indication |
24.5% |
| Asthma |
9.6% |
| Chronic Obstructive Pulmonary Disease |
8.6% |
| Hypertension |
4.4% |
| Pain |
3.5% |
| Prophylaxis |
2.4% |
| Dyspnoea |
2.1% |
| Osteoporosis |
1.8% |
| Depression |
1.6% |
| Emphysema |
1.6% |
| Non-small Cell Lung Cancer |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Atrial Fibrillation |
1.5% |
| Diabetes Mellitus |
1.4% |
| Bronchitis |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Multiple Myeloma |
1.2% |
| Constipation |
1.0% |
| Anxiety |
1.0% |
|
| Vomiting |
13.0% |
| Weight Decreased |
9.4% |
| Pneumonia |
8.9% |
| Dyspnoea |
7.0% |
| Wheezing |
6.3% |
| Death |
4.8% |
| Respiratory Failure |
4.4% |
| Drug Ineffective |
4.4% |
| Urinary Tract Infection |
4.3% |
| Weight Increased |
4.2% |
| Pyrexia |
3.8% |
| Tremor |
3.8% |
| Urticaria |
3.6% |
| Nausea |
3.5% |
| Pulmonary Embolism |
3.4% |
| Vision Blurred |
3.4% |
| Renal Failure Acute |
3.1% |
| Myocardial Infarction |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Thrombocytopenia |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
26.8% |
| Asthma |
22.3% |
| Pain |
13.4% |
| Anxiety |
4.5% |
| Gastrooesophageal Reflux Disease |
4.5% |
| Hypothyroidism |
4.5% |
| Hypercholesterolaemia |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Blood Cholesterol Increased |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Constipation |
2.7% |
| Sleep Disorder |
2.7% |
| Smoking Cessation Therapy |
2.7% |
| Insomnia |
1.8% |
| Hypertension |
0.9% |
| Ill-defined Disorder |
0.9% |
|
| Rash |
30.0% |
| Hypothyroidism |
20.0% |
| Drug Interaction |
15.0% |
| Weight Increased |
10.0% |
| Dyspnoea |
5.0% |
| Hypertension |
5.0% |
| Pain |
5.0% |
| Pneumonia |
5.0% |
| Ulcer |
5.0% |
|
